These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 24091919)

  • 21. New features of systemic vasculitides.
    Yamaguchi M; Izuhara K
    Allergol Int; 2014 Dec; 63(4):503-4. PubMed ID: 25574557
    [No Abstract]   [Full Text] [Related]  

  • 22. 2017 Clinical practice guidelines of the Japan Research Committee of the Ministry of Health, Labour, and Welfare for Intractable Vasculitis for the management of ANCA-associated vasculitis.
    Harigai M; Nagasaka K; Amano K; Bando M; Dobashi H; Kawakami T; Kishibe K; Murakawa Y; Usui J; Wada T; Tanaka E; Nango E; Nakayama T; Tsutsumino M; Yamagata K; Homma S; Arimua Y
    Mod Rheumatol; 2019 Jan; 29(1):20-30. PubMed ID: 30001655
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Editorial.
    Pagnoux C
    Presse Med; 2020 Oct; 49(3):104040. PubMed ID: 32763748
    [No Abstract]   [Full Text] [Related]  

  • 24. Systemic vasculitis: a critical digest of the recent literature.
    Talarico R; Baldini C; Della Rossa A; Carli L; Tani C; Bombardieri S
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S84-8. PubMed ID: 23663686
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Skin involvement in cutaneous and systemic vasculitis.
    Marzano AV; Vezzoli P; Berti E
    Autoimmun Rev; 2013 Feb; 12(4):467-76. PubMed ID: 22959234
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinical stage draws nearer in ongoing studies of gene therapy.
    Simmons K
    JAMA; 1985 Jan; 253(1):13-5. PubMed ID: 3880587
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Systemic vasculitides classification].
    Guillevin L; Terrier B
    Presse Med; 2012 Oct; 41(10):986-95. PubMed ID: 22884126
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Brief Report: Childhood-Onset Systemic Necrotizing Vasculitides: Long-Term Data From the French Vasculitis Study Group Registry.
    Iudici M; Puéchal X; Pagnoux C; Quartier P; Agard C; Aouba A; Büchler M; Cevallos R; Cohen P; de Moreuil C; Guilpain P; Le Quellec A; Roblot P; Serratrice J; Bachmeyer C; Daugas É; Terrier B; Mouthon L; Guillevin L;
    Arthritis Rheumatol; 2015 Jul; 67(7):1959-65. PubMed ID: 25808634
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Recent progress of epidemiological studies on intractable diseases in Japan].
    Yanagawa H
    Nihon Eiseigaku Zasshi; 1995 Feb; 49(6):950-9. PubMed ID: 7723179
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Evolving concepts in classification of systemic vasculitis: where are we and what is the way forward?
    Watts RA
    Int J Rheum Dis; 2019 Jan; 22 Suppl 1():21-27. PubMed ID: 29707909
    [TBL] [Abstract][Full Text] [Related]  

  • 31. What is the value of obesity research?
    Blundell JE; Hebebrand J; Oppert JM
    Obes Facts; 2010 Oct; 3(5):279-82. PubMed ID: 20975292
    [No Abstract]   [Full Text] [Related]  

  • 32. Pulmonary Manifestations of Systemic Vasculitis in Children.
    Cuceoglu MK; Ozen S
    Pediatr Clin North Am; 2021 Feb; 68(1):167-176. PubMed ID: 33228930
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gene therapy: regulatory issues and international approaches to regulation.
    Cohen-Haguenauer O
    Curr Opin Biotechnol; 1997 Jun; 8(3):361-9. PubMed ID: 9206021
    [No Abstract]   [Full Text] [Related]  

  • 34. Human Gene Therapy Subcommittee: minutes of meeting, 29-30 Jul 1991.
    U.S. National Institutes of Health. Recombinant DNA Advisory Committee. Human Gene Therapy Subcommittee
    Hum Gene Ther; 1992 Aug; 3(4):439-55. PubMed ID: 11643020
    [No Abstract]   [Full Text] [Related]  

  • 35. Childhood systemic vasculitis.
    Sag E; Batu ED; Ozen S
    Best Pract Res Clin Rheumatol; 2017 Aug; 31(4):558-575. PubMed ID: 29773273
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beyond project-focused consultation to investigator-focused consultation: the CCTST Integration Committee model.
    Tsevat J; Lindsell CJ; Parr WD; Kues JR; Kissela BM; Heubi EC; Flessa JW; Heubi JE
    Clin Transl Sci; 2014 Feb; 7(1):3-5. PubMed ID: 24456418
    [No Abstract]   [Full Text] [Related]  

  • 37. Characteristics and outcome of intractable vasculitis syndrome in children: Nation-wide survey in Japan.
    Nakano N; Mori M; Umebayashi H; Iwata N; Kobayashi N; Masunaga K; Imagawa T; Murata T; Kinjo N; Nagai K; Miyoshi M; Takei S; Yokota S; Ishii E
    Mod Rheumatol; 2018 Jul; 28(4):697-702. PubMed ID: 29219653
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Treatment of primary systemic necrotizing vasculitides: the role of biotherapies.
    Guillevin L
    Clin Exp Nephrol; 2013 Oct; 17(5):622-627. PubMed ID: 24018402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Departmental and institutional strategies for reducing fraud in clinical research.
    Sessler DI; Kurz A
    Anesth Analg; 2012 Aug; 115(2):474-6. PubMed ID: 22826524
    [No Abstract]   [Full Text] [Related]  

  • 40. Debates, divisions, and decisions: recombinant DNA advisory committee (RAC) authorization of the first human gene transfer experiments.
    Carmen IH
    Am J Hum Genet; 1992 Feb; 50(2):245-60. PubMed ID: 1734711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.